Joint Formulary & PAD

Pentoxifylline - Post-radiation laryngeal fibrosis

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Modified release tablets
Associated Icons :
Off Label
SPC
Restrictions / Comments :

Approved at DTC RSFT JUne 2025

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Pentoxifylline
Indication :
Post-radiation laryngeal fibrosis
Group Name :
Keywords :
post radiation laryngeal fibrosis
Brand Names Include :
Important Information :

For specialist ENT prescribing only

Latest Additions Date From :
18 Jun 2025
Latest Additions Date To :
18 Jul 2025
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Pentoxifylline is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Post-radiation laryngeal fibrosis .

Committee Recommendations (1)

06 Jun 25 - RSFT DTC

Approved. ENT only